Work

A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials

Year: 2011

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-011-9662-0

Authors: Axel Le Cesne, Alejandro Yovine, Jean-Yves Blay, Suzette Delaloge, Robert G. Maki, Jean-Louis Misset, Pilar Frontelo, Antonio Nieto, Juhui James Jiao, George D. Demetri

Institutions: Institut Gustave Roussy, Fondation Gustave Roussy, Hôpital Saint-Louis, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Memorial Sloan Kettering Cancer Center, PharmaMar (Spain), Janssen Research & Development (United States), Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2153205088

FWCI: 3.113

Cites: 39

Cited by: 78

Related to: 10